A new month is about to begin, so it seems fitting that this week's research highlights have lots of "new" initiatives that we're excited to report. A new Collaborative will broaden the scope of genetics medicine at The Children's Hospital of Philadelphia.
It is scary to learn your child has neuroblastoma, a tumor of the peripheral nervous system that is the most common cancer in infants. It is scarier still when you get test results that show your child is in the half of neuroblastoma patients whose cancer is very aggressive and high-risk.
Yesterday, CBS Sunday Morning featured a story on the anaplastic lymphoma kinase, or ALK, clinical trial for lymphoma and neuroblastoma and CHOP’s partnership with the Alex's Lemonade Stand Foundation, which supported the basic research.